Standardization of Coagulation Factor V Reference Intervals, Prothrombin Time, and Activated Partial Thromboplastin Time in Mice for Use in Factor V Deficiency Pathological Models

被引:3
|
作者
De Pablo-Moreno, Juan A. [1 ]
Liras, Antonio [1 ]
Revuelta, Luis [2 ]
机构
[1] Univ Complutense Madrid, Sch Biol, Dept Genet Physiol & Microbiol, Madrid, Spain
[2] Univ Complutense Madrid, Sch Vet Med, Dept Physiol, Madrid, Spain
关键词
factor V; prothrombin time; activated partial thromboplastin time; mouse; measurement standardization; transfusion; pathological models; factor V deficiency; HEMOPHILIA-A; PLASMA; TRANSFUSION; HEMORRHAGE; EVOLUTION; SELECTION;
D O I
10.3389/fvets.2022.846216
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
Factor V together with activated factor X forms the prothrombinase complex, which transforms prothrombin into thrombin. The Mus musculus species is characterized by very high levels of this factor and short clotting times, which hinders accurate measurements. For that reason, a detailed characterization of such parameters is indispensable. A method was designed as part of this study to provide an accurate determination and standardization of factor V levels, prothrombin time and activated partial thromboplastin time in Mus musculus. Those parameters were evaluated in a sample of 66 healthy animals using a semi-automated coagulometer and human diagnostic reagents in an attempt to determine the most appropriate time of day for the extractions. A mouse-based protocol was designed, capable of making corrections to the samples at dilutions of 1:100 for factor V and at of 1:3 for prothrombin time. The goal was to smoothen the calibration curves, which often present with steep slopes and narrow measurement ranges between one calibration point and another. It was found that the most stable period for blood sample extraction was that comprised between the first 6 h of light. No clinical differences were observed between the sexes and reference intervals were established for factor V (95.80% +/- 18.14; 25.21 s +/- 1.34), prothrombin time (104.31% +/- 14.52; 16.85 s +/- 1.32) and activated partial thromboplastin time (32.86 s +/- 3.01). The results obtained are applicable to human or veterinary biomedical research, to transfusional medicine or to pathological models for diseases such as factor V deficiency.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] A Case of Acquired Factor V Deficiency with Correction of Activated Partial Thromboplastin Time and Prothrombin Time Mixing Studies
    Alquran, B.
    Pachika, P.
    Kalantri, S.
    McCoy, M.
    TRANSFUSION, 2024, 64 : 155A - 156A
  • [2] A novel compensating mechanism for homozygous coagulation factor V deficiency suggested by enhanced activated partial thromboplastin time after reconstitution with normal factor V
    Talbot, Kimberley
    Song, Jina
    Hewitt, Jeff
    Serrano, Katherine
    Ho, Michael
    Carter, Cedric J.
    MacGillivray, Ross T. A.
    Pryzdial, Edward L. G.
    BRITISH JOURNAL OF HAEMATOLOGY, 2010, 151 (02) : 198 - 200
  • [3] PROLONGED PROTHROMBIN TIME AND PARTIAL THROMBOPLASTIN TIME IN DISSEMINATED INTRAVASCULAR COAGULATION NOT DUE TO DEFICIENCY OF FACTORS V AND VIII
    MANT, MJ
    HIRSH, J
    PINEO, GF
    LUKE, KH
    BRITISH JOURNAL OF HAEMATOLOGY, 1973, 24 (06) : 725 - 734
  • [4] PARADOXIC EFFECT OF MULTIPLE MILD COAGULATION-FACTOR DEFICIENCIES ON THE PROTHROMBIN TIME AND ACTIVATED PARTIAL THROMBOPLASTIN TIME
    BURNS, ER
    GOLDBERG, SN
    WENZ, B
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1993, 100 (02) : 94 - 98
  • [5] STANDARDIZATION OF PROTHROMBIN AND ACTIVATED PARTIAL THROMBOPLASTIN TIME REAGENTS AND CONTROLS
    PATTERSON, BB
    PULS, JL
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1976, 65 (02) : 213 - 219
  • [6] Verification and Establishment of Reference Intervals for Prothrombin Time and Activated Partial Thromboplastin Time for Children in a Clinical Laboratory
    Lee, Min Young
    Lee, Woo In
    Kang, So Young
    Kim, Myeong Hee
    CLINICAL LABORATORY, 2022, 68 (02) : 367 - 373
  • [7] THE ACTIVATED PARTIAL THROMBOPLASTIN TIME AND FACTOR-XI DEFICIENCY
    SELIGSOHN, U
    ANNALS OF INTERNAL MEDICINE, 1986, 105 (05) : 805 - 805
  • [8] Efficacy of prothrombin time and activated partial thromboplastin time as a gauge for specific factor inhibition
    Keller, C.
    Dennis, J.
    Monroe, D.
    Tidwell, R.
    Church, F.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 906 - 907
  • [9] Factor V Leiden: A reliable screening assay based on activated partial thromboplastin time (APTT)
    Vu, L
    Demers, C
    Jobin, F
    Delage, R
    Jacques, L
    THROMBOSIS AND HAEMOSTASIS, 1997, : PS83 - PS83
  • [10] Anti-factor Xa activity, prothrombin time, and activated partial thromboplastin time in patients treated with factor Xa inhibitors
    Ono, Ryohei
    Nishimura, Kazutaka
    Takahashi, Hidehisa
    Hori, Yasuhiko
    Fukushima, Kenichi
    Kobayashi, Yoshio
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2023, 396 (02) : 323 - 336